Preclinical evaluation of radiosensitizing activity of Pluronic block copolymers

References

• Alakhov V, Moskaleva E, Batrakova EV, Kabanov AV. 1996. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjugate Chemistry 7:209–216.
   PubMed Web of Science ®Google Scholar
• Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A. 1999. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharmaceutical Research 16:1373–1379.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW, Kabanov AV. 2001. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: Contributions of energy depletion and membrane fluidization. Journal of Pharmacology and Experimental Therapeutics 299:483–493.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Li S, Li Y, Alakhov VY, Elmquist WF, Kabanov AV. 2004. Distribution kinetics of a micelle-forming block copolymer Pluronic P85. Journal of Controlled Release 100:389–397.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Vinogradov SV, Robinson SM, Niehoff ML, Banks WA, Kabanov AV. 2005. Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. Bioconjugate Chemistry 16:793–802.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. 2008. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. Journal of Controlled Release 130:98–106.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Li S, Brynskikh AM, Sharma AK, Li Y, Boska M, Gong N, Mosley RL, Alakhov VY, Gendelman HE, Kabanov AV. 2010. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. Journal of Controlled Release 143:290–301.
   PubMed Web of Science ®Google Scholar
• Bisht KS, Bradbury CM, Mattson D, Kaushal A, Sowers A, Markovina S, Ortiz KL, Sieck LK, Isaacs JS, Brechbiel MW, Mitchell JB, Neckers LM, Gius D. 2003. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Research 63:8984–8995.
   PubMed Web of Science ®Google Scholar
• Bull EE, Dote H, Brady KJ, Burgan WE, Carter DJ, Cerra MA, Oswald KA, Hollingshead MG, Camphausen K, Tofilon PJ. 2004. Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin. Clinical Cancer Research 10:8077–8084.
   PubMed Web of Science ®Google Scholar
• Chiappetta DA, Sosnik A. 2007. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 66:303–317.
   PubMed Web of Science ®Google Scholar
• Drysdale MJ, Brough PA, Massey A, Jensen MR, Schoepfer J. 2006. Targeting Hsp90 for the treatment of cancer. Current Opinion in Drug Discovery & Development 9:483–495.
   PubMed Web of Science ®Google Scholar
• Dungey FA, Caldecott KW, Chalmers AJ. 2009. Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90. Molecular Cancer Therapeutics 8:2243–2254.
   PubMed Web of Science ®Google Scholar
• Durrett R, Foo J, Leder K, Mayberry J, Michor F. 2011. Intratumor heterogeneity in evolutionary models of tumor progression. Genetics 188:461–477.
   PubMed Web of Science ®Google Scholar
• Enmon R, Yang WH, Ballangrud AM, Solit DB, Heller G, Rosen N, Scher HI, Sgouros G. 2003. Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids. Cancer Research 63:8393–8399.
   PubMed Web of Science ®Google Scholar
• Exner AA, Krupka TM, Scherrer K, Teets JM. 2005. Enhancement of carboplatin toxicity by Pluronic block copolymers. Journal of Controlled Release 106:188–197.
   PubMed Web of Science ®Google Scholar
• Ferrarini M, Heltai S, Zocchi MR, Rugarli C. 1992. Unusual expression and localization of heat-shock proteins in human tumor cells. International Journal of Cancer 51:613–619.
   PubMed Web of Science ®Google Scholar
• Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. 2007. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes & Development 21:2683–2710.
   PubMed Web of Science ®Google Scholar
• Gerweck LE, Vijayappa S, Kurimasa A, Ogawa K, Chen DJ. 2006. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Research 66:8352–8355.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ, Muschel RJ, McKenna WG. 2001. The Ras radiation resistance pathway. Cancer Research 61:4278–4282.
   PubMed Web of Science ®Google Scholar
• Harashima K, Akimoto T, Nonaka T, Tsuzuki K, Mitsuhashi N, Nakano T. 2005. Heat shock protein 90 (Hsp90) chaperone complex inhibitor, radicicol, potentiated radiation-induced cell killing in a hormone-sensitive prostate cancer cell line through degradation of the androgen receptor. International Journal of Radiation Biology 81: 63–76.
   PubMed Web of Science ®Google Scholar
• Harrison EM, Sharpe E, Bellamy CO, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ. 2008. Heat shock protein 90-binding agents protect renal cells from oxidative stress and reduce kidney ischemia-reperfusion injury. American Journal of Physiology 295:F397–405.
   Google Scholar
• Inda MM, Bonavia R, Mukasa A, Narita Y, Sah DW, Vandenberg S, Brennan C, Johns TG, Bachoo R, Hadwiger P, Tan P, Depinho RA, Cavenee W, Furnari F. 2010. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes and Development 24:1731–1745.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. 2002. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of Controlled Release 82:189–212.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. 2003. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. Journal of Controlled Release 91:75–83.
   PubMed Web of Science ®Google Scholar
• Krupka TM, Weinberg BD, Ziats NP, Haaga JR, Exner AA. 2006. Injectable polymer depot combined with radiofrequency ablation for treatment of experimental carcinoma in rat. Investigative Radiology 41:890–897.
   PubMed Web of Science ®Google Scholar
• Krupka TM, Weinberg BD, Wu H, Ziats NP, Exner AA. 2007. Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats. Experimental Biology and Medicine (Maywood) 232:950–957.
   PubMed Web of Science ®Google Scholar
• Krupka TM, Exner AA. 2011. Structural parameters governing activity of Pluronic triblock copolymers in hyperthermia cancer therapy. International Journal of Hyperthermia 27:663–671.
   PubMed Web of Science ®Google Scholar
• Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ. 1998. Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro. International Journal of Radiation Oncology, Biology, Physics 41:875–882.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Choi SA,Lee KH,Chung HY, Kim TH, Cho CK, Lee YS. 2001. Role of inducible heat shock protein 70 in radiation-induced cell death. Cell Stress Chaperones 6:273–281.
   PubMed Web of Science ®Google Scholar
• Louis DN. 2006. Molecular pathology of malignant gliomas. Annual Review of Pathology 1:97–117.
   PubMed Web of Science ®Google Scholar
• Machida H, Matsumoto Y, Shirai M, Kubota N. 2003. Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation. International Journal of Radiation Biology 79:973–980.
   PubMed Web of Science ®Google Scholar
• Meyn RE. 1997. Apoptosis and response to radiation: Implications for radiation therapy. Oncology (Williston Park) 11:349–356; discussion 356, 361, 365.
   PubMedGoogle Scholar
• Morimoto RI, Kline MP, Bimston DN, Cotto JJ. 1997. The heat-shock response: Regulation and function of heat-shock proteins and molecular chaperones. Essays in Biochemistry 32:17–29.
   PubMed Web of Science ®Google Scholar
• Neckers L. 2002. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends in Molecular Medicine 8:S55–61.
   PubMed Web of Science ®Google Scholar
• Noguchi M, Yu D, Hirayama R, Ninomiya Y, Sekine E, Kubota N, Ando K, Okayasu R. 2006. Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Biochemical and Biophysical Research Communications 351:658–663.
   PubMed Web of Science ®Google Scholar
• Peng B, Xu L, Cao F, Wei T, Yang C, Uzan G, Zhang D. 2010. HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way. Molecular Cancer 9:79.
   PubMed Web of Science ®Google Scholar
• Perera RH, Krupka TM, Wu H, Traughber B, Dremann D, Broome AM, Exner AA. 2011. Role of Pluronic block copolymers in modulation of heat shock protein 70 expression. International Journal of Hyperthermia 27:672–681.
   PubMed Web of Science ®Google Scholar
• Pirollo KF, Hao Z, Rait A, Ho CW, and Chang EH. 1997. Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells. Biochemical and Biophysical Research Communications 230:196–201.
   PubMed Web of Science ®Google Scholar
• Price BD, Calderwood SK. 1991. Ca2 + is essential for multistep activation of the heat shock factor in permeabilized cells. Molecular and Cellular Biology 11:3365–3368.
   PubMed Web of Science ®Google Scholar
• Price TO, Farr SA, Yi X, Vinogradov S, Batrakova E, Banks WA, Kabanov AV. 2010. Transport across the blood-brain barrier of pluronic leptin. The Journal of Pharmacology and Experimental Therapeutics 333:253–263.
   PubMed Web of Science ®Google Scholar
• Psarros TG, Mickey B, Gilio J, Drees J, Gall K, Carlson D, Giller C, Willis MS. 2005. Gliosarcoma cell death after radiosurgery in a rat model. Minimally Invasive Neurosurgery 48:142–148.
   PubMedGoogle Scholar
• Russell JS, Burgan W, Oswald KA, Camphausen K, Tofilon PJ. 2003. Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin: A multitarget approach to radiosensitization. Clinical Cancer Research 9:3749–3755.
   PubMed Web of Science ®Google Scholar
• Sato S, Fujita N, Tsuruo T. 2000. Modulation of Akt kinase activity by binding to Hsp90. Proceedings of the National Academy of Sciences of the USA 97:10832–10837.
   PubMed Web of Science ®Google Scholar
• Schulte TW, Blagosklonny MV, Ingui C, Neckers L. 1995. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. The Journal of Biological Chemistry 270:24585–24588.
   PubMed Web of Science ®Google Scholar
• Shintani S, Mihara M, Li C, Nakahara Y, Hino S, Nakashiro K, Hamakawa H. 2003. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Science 94:894–900.
   PubMed Web of Science ®Google Scholar
• Shpund S, Gershon D. 1997. Alterations in the chaperone activity of HSP70 in aging organisms. Archives of Gerontology and Geriatrics 24:125–131.
   PubMed Web of Science ®Google Scholar
• Sun Y, Huang YC, Xu QZ, Wang HP, Bai B, Sui JL, Zhou PK. 2006. HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair, and sensitizes cells to ionizing radiation. International Journal of Radiation Oncology, Biology, Physics 65:842–850.
   PubMed Web of Science ®Google Scholar
• Tanno S, Yanagawa N, Habiro A, Koizumi K, Nakano Y, Osanai M, Mizukami Y, Okumura T, Testa JR, Kohgo Y. 2004. Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance. Cancer Research 64:3486–3490.
   PubMed Web of Science ®Google Scholar
• Wang QE, Milum K, Han C, Huang YW, Wani G, Thomale J, Wani AA. 2011. Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells. Molecular Cancer 10:24.
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang H, Burrows F, Zhang L, Shores CG. 2005. Potent activity of a novel dimeric heat shock protein 90 inhibitor against head and neck squamous cell carcinoma in vitro and in vivo. Clinical Cancer Research 11:3889–3896.
   PubMed Web of Science ®Google Scholar
• Zhao M, Ma J, Zhu HY, Zhang XH, Du ZY, Xu YJ, Yu XD. 2011. Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90. Molecular Cancer 10:104.
   PubMed Web of Science ®Google Scholar